| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/08/2010 | US20100086545 Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
| 04/08/2010 | US20100086544 Compositions and methods for treating a neoplasm |
| 04/08/2010 | US20100086543 Compositions and methods for treating conditions associated with ceramide biosynthesis |
| 04/08/2010 | US20100086542 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
| 04/08/2010 | US20100086541 Regulation of autophagy pathway phosphorylation and uses thereof |
| 04/08/2010 | US20100086540 Co-crystal of antibody 11f8fab fragment and egfr extracellular domain and uses thereof |
| 04/08/2010 | US20100086539 Method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 04/08/2010 | US20100086538 Antibody Molecules Which Bind to Human IL-17 |
| 04/08/2010 | US20100086537 Polynucleotides and polypeptide sequences involved in cancer |
| 04/08/2010 | US20100086517 Enhancement of B cell proliferation by IL-15 |
| 04/08/2010 | US20100086516 Cytokine receptor chain |
| 04/08/2010 | US20100086490 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/08/2010 | US20100086486 Genetically modified human natural killer cell lines |
| 04/08/2010 | US20100086485 Influenza vaccine |
| 04/08/2010 | CA2739473A1 New hcv entry factor, occludin |
| 04/08/2010 | CA2739454A1 Methods for the treatment of graft-versus-host disease |
| 04/08/2010 | CA2739387A1 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 04/08/2010 | CA2739384A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 04/08/2010 | CA2739083A1 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | CA2739050A1 Antibodies against il-25 |
| 04/08/2010 | CA2739038A1 Non-human mammals for the production of chimeric antibodies |
| 04/08/2010 | CA2738993A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-releasing hormone (gnrh) as immunogen |
| 04/08/2010 | CA2738793A1 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 04/08/2010 | CA2738664A1 Bovine herpes virus -1 compositions, vaccines and methods |
| 04/08/2010 | CA2738660A1 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 04/08/2010 | CA2738621A1 Anthrax vaccine formulation and uses thereof |
| 04/08/2010 | CA2738583A1 Methods for the treatment of cancer |
| 04/08/2010 | CA2738496A1 Compositions for proliferation of cells and related methods |
| 04/08/2010 | CA2736929A1 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 04/08/2010 | CA2736429A1 Anti-notch2 antibodies and methods of use |
| 04/08/2010 | CA2730261A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 04/07/2010 | EP2172552A2 Recombinant nucleic acids comprising regions of AD6 |
| 04/07/2010 | EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/07/2010 | EP2172543A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 04/07/2010 | EP2172488A1 Material with immunogenicity |
| 04/07/2010 | EP2172487A1 Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| 04/07/2010 | EP2172486A2 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 04/07/2010 | EP2172483A1 ANTI-Muc17 ANTIBODY |
| 04/07/2010 | EP2172476A2 Compositions and methods for WT1 specific immunotherapy |
| 04/07/2010 | EP2172219A1 Anti-cancer agent comprising an iNKT ligand and anti-PD-1 antibody or anti-PD-L1 antibody |
| 04/07/2010 | EP2172217A1 Fibrosis inhibitor |
| 04/07/2010 | EP2172216A2 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| 04/07/2010 | EP2172215A2 Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2172213A2 Injectable vaccines against multiple meningococcal serogroups |
| 04/07/2010 | EP2172212A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 04/07/2010 | EP2172211A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 04/07/2010 | EP2171455A2 Rapid generation of t cell-independent antibody responses to t cell-dependent antigens |
| 04/07/2010 | EP2171451A2 Methods for treating juvenile idiopathic arthritis |
| 04/07/2010 | EP2171448A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 04/07/2010 | EP2171060A2 Superagonistic anti-cd28 antibody |
| 04/07/2010 | EP2170959A1 Antibodies to human programmed death receptor pd-1 |
| 04/07/2010 | EP2170956A2 Treatment of tumors using specific anti-l1 antibody |
| 04/07/2010 | EP2170955A2 Anti ephb4 antibodies and antibody fragments |
| 04/07/2010 | EP2170954A1 Methods of selecting host resistant animals |
| 04/07/2010 | EP2170953A1 Monoclonal anti beta amyloid antibody |
| 04/07/2010 | EP2170951A2 Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering |
| 04/07/2010 | EP2170929A2 Peptides facilitating retrograde transport and their uses |
| 04/07/2010 | EP2170392A2 Composition and method for treatment of autoimmune disease |
| 04/07/2010 | EP2170391A1 Modified polysaccharides for conjugate vaccines |
| 04/07/2010 | EP2170390A2 Antibody formulations |
| 04/07/2010 | EP2170389A1 Humanized antibodies to amyloid beta |
| 04/07/2010 | EP2170388A1 Antibody formulations |
| 04/07/2010 | EP2170387A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 04/07/2010 | EP2170386A1 Use of intranasally administered pidotimod to enhance antigen-specific humoral and cell-mediated immune response |
| 04/07/2010 | EP2170385A2 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 04/07/2010 | EP2170383A1 Vaccines containing canine parvovirus genetic variants |
| 04/07/2010 | EP2170382A1 An attenuated influenza virus and a live vaccine comprising the same |
| 04/07/2010 | EP2170380A1 Capsid proteins and uses therefore |
| 04/07/2010 | EP2170379A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 04/07/2010 | EP2170378A2 Method of protecting against staphylococcal infection |
| 04/07/2010 | EP2170377A1 Mutated e. coli heat-labile enterotoxin |
| 04/07/2010 | EP2170376A1 Multi-day delivery of biologically active substances |
| 04/07/2010 | EP2170372A1 Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
| 04/07/2010 | EP2170276A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 04/07/2010 | EP2170268A2 Compositions of specific binding agents to hepatocyte growth factor |
| 04/07/2010 | EP1723168B1 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 04/07/2010 | EP1692182B1 Cd20 antibodies with increased fc receptor binding affinity and effector function |
| 04/07/2010 | EP1590047B1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 04/07/2010 | EP1379552B1 Toll-like receptor 5 ligands and methods of use |
| 04/07/2010 | EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 04/07/2010 | CN1769298B Fusion protein with antitumour action and its coding gene and uses |
| 04/07/2010 | CN1764472B Injectable vaccines against multiple meningococcal serogroups |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691406A New fusion protein SSI, application and special gene thereof |
| 04/07/2010 | CN101691405A Fusion antigen uses as vaccine |
| 04/07/2010 | CN101690821A Immune protective agent of attenuated living vaccine against infectious bursal disease and preparation method thereof |
| 04/07/2010 | CN101690813A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof |
| 04/07/2010 | CN101690812A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof |
| 04/07/2010 | CN101690811A Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof |
| 04/07/2010 | CN101690810A Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof |
| 04/07/2010 | CN101690809A Propolis-astragalus polysaccharides compound nanometer emulsion adjuvant and preparation method and application thereof |
| 04/07/2010 | CN101690808A Method for preparing swine fever-pseudorabies bigeminal live vaccine and product thereof |
| 04/07/2010 | CN101690807A Riemerella anatipestifer and escherichia coli bigeminal inactivated vaccine, and preparation method thereof |
| 04/07/2010 | CN101690806A schistosomiasis japonica arborization carrier-DNA vaccine and preparation method thereof |
| 04/07/2010 | CN101690805A Preparation process of dendritic cell targeted nanoliposome tumor vaccine |
| 04/07/2010 | CN101690715A Method for preparing immunoglobulin G liposome by using milk fat globule membrane phospholipids |
| 04/06/2010 | US7691994 Compositions and methods for the detection of human T cell receptor variable family gene expression |